Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2015, Article ID 736213, 4 pages
http://dx.doi.org/10.1155/2015/736213
Case Report

A Case of Primary Renal Carcinoid Tumor

Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki 036-8562, Japan

Received 17 September 2014; Revised 28 November 2014; Accepted 5 January 2015

Academic Editor: Mohsen Farsad

Copyright © 2015 Toshikazu Tanaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. M. Modlin and A. Sandor, “An analysis of 8305 cases of carcinoid tumors,” Cancer, vol. 79, no. 4, pp. 813–829, 1997. View at Publisher · View at Google Scholar
  2. R. Murali, K. Kneale, N. Lalak, and W. Delprado, “Carcinoid tumors of the urinary tract and prostate,” Archives of Pathology and Laboratory Medicine, vol. 130, no. 11, pp. 1693–1706, 2006. View at Google Scholar · View at Scopus
  3. A. O. Omiyale and A. K.-G. Venyo, “Primary carcinoid tumour of the kidney: a review of the literature,” Advances in Urology, vol. 2013, Article ID 579396, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Krishnan, L. D. Truong, G. Saleh, D. M. Sirbasku, and K. M. Slawin, “Horseshoe kidney is associated with an increased relative risk of primary renal carcinoid tumor,” Journal of Urology, vol. 157, no. 6, pp. 2059–2066, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Jain, M. C. Sharma, K. Singh, and N. P. Gupta, “Primary carcinoid tumor of the kidney: case report and brief review of literature,” Indian Journal of Pathology and Microbiology, vol. 53, no. 4, pp. 772–774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Guy, L. R. Bégin, L. L. Oligny, G. B. Brock, S. Chevalier, and A. G. Aprikian, “Searching for an intrinsic neuroendocrine cell in the kidney: an immunohistochemical study of the fetal, infantile and adult kidne,” Pathology Research and Practice, vol. 195, no. 1, pp. 25–30, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. McCaffrey, V. Reuter, H. W. Herr, H. A. Macapinlac, P. Russo, and R. J. Motzer, “Carcinoid tumor of the kidney: the use of somatostatin receptor scintigraphy in diagnosis and management,” Urologic Oncology, vol. 5, no. 3, pp. 108–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. D. E. Hansel, J. I. Epstein, E. Berbescu, S. W. Fine, R. H. Young, and J. C. Cheville, “Renal carcinoid tumor: a clinicopathologic study of 21 cases,” American Journal of Surgical Pathology, vol. 31, no. 10, pp. 1539–1544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. F. Raslan, J. Y. Ro, N. G. Ordonez et al., “Primary carcinoid of the kidney. Immunohistochemical and ultrastructural studies of five patients,” Cancer, vol. 72, no. 9, pp. 2660–2666, 1993. View at Publisher · View at Google Scholar
  10. F. R. Romero, S. Rais-Bahrami, S. Permpongkosol, S. W. Fine, S. Kohanim, and T. W. Jarrett, “Primary carcinoid tumors of the kidney,” The Journal of Urology, vol. 176, no. 6, part 1, pp. 2359–2366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kurl, H. Rytkönen, P. Farin, M. Ala-Opas, and S. Soimakallio, “A primary carcinoid tumor of the kidney: a case report and review of the literature,” Abdominal Imaging, vol. 21, no. 5, pp. 464–467, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. D. K. McKeown, G.-K. Nguyen, B. Rudrick, and M. A. Johnson, “Carcinoid of the kidney: radiologic findings,” American Journal of Roentgenology, vol. 150, no. 1, pp. 143–144, 1987. View at Google Scholar · View at Scopus
  13. M. Gabriel, A. Oberauer, G. Dobrozemsky et al., “68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy,” Journal of Nuclear Medicine, vol. 50, no. 9, pp. 1427–1434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. N. Eble, J. I. Epstein, and I. A. Sesterhenn, World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, Lyon IARC Press, 2004.
  15. J. Lüttges, “What’s new?: the 2010 WHO classification for tumours of the pancreas,” Pathologe, vol. 32, supplement 2, pp. 332–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Korkmaz, S. Seber, D. Yavuzer, M. Gumus, and N. S. Turhal, “Primary renal carcinoid: treatment and prognosis,” Critical Reviews in Oncology/Hematology, vol. 87, no. 3, pp. 256–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. F. Quinchon, S. Aubert, J. Biserte, L. Lemaitre, B. Gosselin, and X. Leroy, “Primary atypical carcinoid of the kidney: a classification is needed,” Pathology, vol. 35, no. 4, pp. 353–355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Litwinowicz, J. Szpor, G. Januś, M. Worek, and K. Okoń, “Primary carcinoid tumour in horseshoe kidney,” Polish Journal of Pathology, vol. 62, no. 1, pp. 72–74, 2011. View at Google Scholar · View at Scopus
  19. H. Kajiwara, K. Hirabayashi, M. Miyazawa et al., “Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix,” Archives of Gynecology and Obstetrics, vol. 279, no. 4, pp. 521–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Rinke, H.-H. Müller, C. Schade-Brittinger et al., “Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group,” Journal of Clinical Oncology, vol. 27, no. 28, pp. 4656–4663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Yao, A. T. Phan, D. Z. Chang et al., “Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study,” Journal of Clinical Oncology, vol. 26, no. 26, pp. 4311–4318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Kunikowska, L. Królicki, A. Hubalewska-Dydejczyk, R. Mikołajczak, A. Sowa-Staszczak, and D. Pawlak, “Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 10, pp. 1788–1797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Öberg, U. Knigge, D. Kwekkeboom, and A. Perren, “Neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 23, supplement 7, Article ID mds295, pp. vii124–vii130, 2012. View at Publisher · View at Google Scholar · View at Scopus